Ireland
--:--IST
Active, not recruiting Observational

Westlake Frequent-sampling Cohort 2

NCT07606885 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2026-02-15
Last updated
2026-09-29

Condition(s) studied

Health AdultsStability of Microbiome

Study summary

This observational follow-up study extends a previously completed 15-day intensive longitudinal study (WeF) of the gut microbiome in healthy adults. The objective of WeF2 is to characterize the long-term stability and dynamics of the gut and oral microbiota in the same cohort across multiple timescales, and to determine whether the day-to-day variability patterns observed at baseline persist over months and years. Participants who completed the WeF baseline protocol will be invited to attend periodic follow-up visits for low-frequency biospecimen collection and to repeat the original 15-day high-frequency sampling protocol at planned intervals, beginning approximately six months after the WeF baseline and continuing at extended intervals thereafter. By combining sparse routine sampling with recurring high-density sampling windows, the study aims to distinguish the stable core microbiome from transient and seasonal fluctuations, to track gradual community shifts under free-living conditions, and to further explore relationships among microbiome dynamics, dietary intake, and host glycemic regulation over an extended observation period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants reside in Hangzhou Exclusion Criteria: * Refusing or unable to give informed consent * Participants with chronic gastrointestinal diseases and take daily relevant medications * Participants with metabolic diseases including diabetes, hypertension and cardiovascular diseases (CVD) * Participants with craniocerebral trauma, cancer, liver disease, kidney disease, or other critical illness, or history of operation or medication * Participants with bulimia nervosa, post-traumatic stress disorder (PTSD), chronic anxiety and depression or other critical neuronal disorder or history of relevant medication * Being or to be pregnant or lactating. * Participants with history of alcohol or drug addiction, or smoke above 15 cigarettes per day * Concurrently participating other clinical trials.

Primary outcome measure(s)

  • Gut microbiome — 3 years
    Description: Using qPCR, metagenomics, metabolomics, proteomics, and culturomics, we quantified the composition and absolute abundance of the gut microbiota and characterized its short-term and long-term dynamics.

Trial sites (1)

FacilityCityRegionStatus
Westlake University Hangzhou Zhejiang
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07606885 on ClinicalTrials.gov ↗ ← All trials in China